• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of High-Frequency Chest Wall Oscillation Expectoration System on Pulmonary Rehabilitation and Cortisol Function in Patients with Severe AECOPD.高频胸壁振荡排痰系统对重症 AECOPD 患者肺康复及皮质醇功能的影响。
Dis Markers. 2022 Jul 22;2022:3380048. doi: 10.1155/2022/3380048. eCollection 2022.
2
Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency Chest Wall Oscillation in Patients With COPD Coupled With Pneumonia.哌拉西林他唑巴坦联合高频胸壁振荡治疗慢性阻塞性肺疾病合并肺炎患者的疗效与安全性分析
Altern Ther Health Med. 2023 Jan;29(1):124-129.
3
Safety and effectiveness of the high-frequency chest wall oscillation vs intrapulmonary percussive ventilation in patients with severe COPD.高频胸壁振荡与肺内叩击通气治疗重度慢性阻塞性肺疾病患者的安全性及有效性
Int J Chron Obstruct Pulmon Dis. 2018 Feb 16;13:617-625. doi: 10.2147/COPD.S145440. eCollection 2018.
4
Effects of High-Frequency Chest Wall Oscillation on Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.高频胸壁振荡对慢性阻塞性肺疾病急性加重的影响:一项随机对照试验的系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2022 Nov 10;17:2857-2869. doi: 10.2147/COPD.S378642. eCollection 2022.
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
6
Value of refined care in patients with acute exacerbation of chronic obstructive pulmonary disease.精细化护理在慢性阻塞性肺疾病急性加重期患者中的价值
World J Clin Cases. 2021 Jul 26;9(21):5840-5849. doi: 10.12998/wjcc.v9.i21.5840.
7
[A study of the value of high frequency chest wall oscillation in patients with acute exacerbation of chronic obstructive pulmonary disease].[高频胸壁振荡对慢性阻塞性肺疾病急性加重期患者的价值研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2014 Apr;37(4):255-9.
8
[Meta-analysis and trial sequential analysis of modified Sangbaipi Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].[桑白皮汤加减治疗慢性阻塞性肺疾病急性加重期的Meta分析与试验序贯分析]
Zhongguo Zhong Yao Za Zhi. 2019 Sep;44(17):3806-3815. doi: 10.19540/j.cnki.cjcmm.20190419.501.
9
Efficacy of high-frequency chest wall oscillations vs. lung flute in chronic obstructive pulmonary disease patients with post-COVID.高频胸壁振荡与肺笛治疗新冠后慢性阻塞性肺疾病患者的疗效比较。
Eur Rev Med Pharmacol Sci. 2024 Feb;28(3):1227-1233. doi: 10.26355/eurrev_202402_35361.
10
[Procalcitonin impact analysis, respiratory function and blood gas analysis on Xiaoqinglong decoction combined with non-invasive ventilation in treatment of AECOPD patients].[降钙素原影响分析、呼吸功能及血气分析对小青龙汤联合无创通气治疗慢性阻塞性肺疾病急性加重期患者的作用]
Zhongguo Zhong Yao Za Zhi. 2018 Jul;43(14):3026-3030. doi: 10.19540/j.cnki.cjcmm.20180327.002.

引用本文的文献

1
Airway clearance techniques for people with acute exacerbation of COPD: a scoping review.慢性阻塞性肺疾病急性加重患者的气道廓清技术:一项范围综述
Eur Respir Rev. 2025 Jan 22;34(175). doi: 10.1183/16000617.0191-2024. Print 2025 Jan.

本文引用的文献

1
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
2
AECOPD research in the past ten years: a bibliographic analysis based on Web of Science.过去十年中 AECOPD 的研究:基于 Web of Science 的文献计量分析。
Ann Palliat Med. 2021 Oct;10(10):10401-10413. doi: 10.21037/apm-21-2756.
3
Serum cortisol levels and adrenal gland size in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的血清皮质醇水平和肾上腺大小
Am J Transl Res. 2021 Jul 15;13(7):8150-8157. eCollection 2021.
4
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.慢性阻塞性肺疾病恶化基础:诊断、治疗、预防和疾病影响。
Respirology. 2021 Jun;26(6):532-551. doi: 10.1111/resp.14041. Epub 2021 Apr 24.
5
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
6
Does High-Frequency Chest Wall Oscillation Have an Impact on Improving Pulmonary Function in Patients With Smoke Inhalation Injury?高频胸壁振荡对改善烟雾吸入伤患者肺功能的影响
J Burn Care Res. 2021 Mar 4;42(2):300-304. doi: 10.1093/jbcr/iraa147.
7
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.慢性阻塞性肺疾病加重的定义、病因、发病机制及后果。
Clin Chest Med. 2020 Sep;41(3):421-438. doi: 10.1016/j.ccm.2020.06.007.
8
Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病。
Ann Intern Med. 2020 Aug 4;173(3):ITC17-ITC32. doi: 10.7326/AITC202008040.
9
High flow nasal therapy during early pulmonary rehabilitation in patients with acute severe exacerbation of COPD: beneficial or illusory?高流量鼻导管氧疗在 COPD 急性加重期患者早期肺康复中的作用:有益还是虚幻?
Respir Res. 2020 Jun 12;21(1):150. doi: 10.1186/s12931-020-01415-y.
10
Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits.慢性阻塞性肺疾病急性加重:寻找诊断生物标志物和可治疗特征。
Thorax. 2020 Jun;75(6):520-527. doi: 10.1136/thoraxjnl-2019-214484. Epub 2020 Mar 26.

高频胸壁振荡排痰系统对重症 AECOPD 患者肺康复及皮质醇功能的影响。

Effects of High-Frequency Chest Wall Oscillation Expectoration System on Pulmonary Rehabilitation and Cortisol Function in Patients with Severe AECOPD.

机构信息

Rehabilitation Department, Fourth Hospital of Changsha, Changsha 410005, China.

出版信息

Dis Markers. 2022 Jul 22;2022:3380048. doi: 10.1155/2022/3380048. eCollection 2022.

DOI:10.1155/2022/3380048
PMID:35909888
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9337934/
Abstract

OBJECTIVE

To investigate the effect of high-frequency chest wall oscillatory expectoration system (HFCWO) on pulmonary rehabilitation and cortisol function in patients with severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

METHODS

The 65 severe AECOPD patients admitted to our hospital from January 2019 to May 2020 were divided into group A with 33 cases and group B with 32 cases by random number table method. After 14 days of intervention, the improvement time of clinical symptoms in the two groups was recorded, and blood gas, lung function, inflammatory, and cortisol function-related indicators were evaluated before and after treatment.

RESULTS

The remission time of expectoration, pulmonary signs, and hospital stay in group A were significantly shorter than those in group B ( < 0.05). Compared with before treatment, blood oxygen partial pressure (PaO), forced vital capacity (FVC), forced expiratory volume at 1 s (EFV1), and EFV1/FVC increased significantly; blood carbon dioxide partial pressure (PaCO), C-reactive protein (CRP), interleukin-6 (IL-6), white blood cell count (WBC), plasma cortisol (COR), and adrenocorticotropic hormone (ACTH) levels were significantly decreased, and the above indicators in group A increased or decreased more significantly than those in group B ( < 0.05); there was no significant difference in tolerance and adverse reactions between the two groups ( > 0.05).

CONCLUSION

HFCWO has good pulmonary rehabilitation effect in the treatment of severe AECOPD and can significantly improve the blood gas indexes, inflammation, and cortisol function of patients, which is safe and feasible.

摘要

目的

探讨高频胸壁振荡排痰系统(HFCWO)对慢性阻塞性肺疾病急性加重期(AECOPD)患者肺康复及皮质醇功能的影响。

方法

选取我院 2019 年 1 月至 2020 年 5 月收治的 65 例重度 AECOPD 患者,采用随机数字表法分为 A 组(n=33)和 B 组(n=32)。两组均接受常规治疗,A 组在此基础上联合 HFCWO 治疗,比较两组患者的临床症状改善时间,并评价治疗前后血气、肺功能、炎症指标及皮质醇功能相关指标。

结果

A 组患者的排痰、肺部啰音及住院时间均明显短于 B 组( < 0.05)。与治疗前比较,两组患者的血氧分压(PaO)、用力肺活量(FVC)、第 1 秒用力呼气容积(EFV1)、EFV1/FVC 均明显升高,血二氧化碳分压(PaCO)、C 反应蛋白(CRP)、白细胞介素-6(IL-6)、白细胞计数(WBC)、血浆皮质醇(COR)、促肾上腺皮质激素(ACTH)水平均明显降低,且 A 组上述指标的改善程度更为显著( < 0.05);两组患者的耐受度和不良反应发生率比较差异均无统计学意义( > 0.05)。

结论

HFCWO 治疗重度 AECOPD 患者具有良好的肺康复效果,可显著改善患者的血气指标、炎症反应及皮质醇功能,且安全性较高。